Common Poisoning and Toxidromes: Acetaminophen, Salicylate, and Clinical Recognition

Poisoning represents a leading cause of emergency department visits and accounts for significant morbidity and mortality worldwide. The three most clinically relevant toxic exposures are acetaminophen, salicylates, and the recognition of toxidromes - characteristic constellations of signs and symptoms that suggest specific classes of toxins.

[KEY_CONCEPT] Acetaminophen toxicity is the leading cause of acute liver failure in the United States, responsible for >50% of cases. The mechanism involves depletion of hepatic glutathione stores when the normal conjugation pathways (glucuronidation and sulfation) become saturated. The toxic metabolite N-acetyl-p-benzoquinone imine (NAPQI) accumulates and causes hepatocellular necrosis.

Salicylate poisoning disrupts cellular metabolism through multiple mechanisms:

• Uncoupling of oxidative phosphorylation leading to hyperthermia
• Direct stimulation of respiratory centers causing respiratory alkalosis
• Interference with Krebs cycle leading to metabolic acidosis
• Altered glucose metabolism causing CNS dysfunction

[HIGH_YIELD] Toxidromes are clinical syndromes that help identify the class of toxin before laboratory confirmation:

[CLINICAL_PEARL] The mnemonic "Mad as a hatter, red as a beet, hot as a hare, dry as a bone, blind as a bat" describes anticholinergic toxicity.

Acetaminophen Toxicity

Phase I (0-24 hours): Often asymptomatic or nonspecific symptoms

• Nausea, vomiting, malaise
• Diaphoresis, pallor
• [CLINICAL_PEARL] Many patients feel well during this critical window for antidote administration

Phase II (24-72 hours): Apparent recovery

• Resolution of initial symptoms
• Rising aminotransferases and bilirubin
• Right upper quadrant pain may develop

Phase III (72-96 hours): Hepatotoxicity peaks

• Fulminant hepatic failure with encephalopathy
• Coagulopathy (elevated PT/INR)
• Metabolic acidosis and hypoglycemia
• Acute kidney injury (25% of severe cases)

Phase IV (4-14 days): Recovery or death

• Gradual normalization of liver function or progression to liver transplantation

Salicylate Toxicity

[HIGH_YIELD] Early signs (mild to moderate toxicity):

• Tinnitus and hearing loss (reversible)
• Nausea, vomiting, epigastric pain
• Tachypnea due to direct respiratory stimulation
• Confusion, agitation

Severe toxicity features:

• Altered mental status ranging from confusion to coma
• Hyperthermia from uncoupled oxidative phosphorylation
• Noncardiogenic pulmonary edema
• Cerebral edema (especially in children)
• Coagulopathy from decreased vitamin K synthesis

[KEY_CONCEPT] Mixed acid-base disorder is pathognomonic:

• Initial respiratory alkalosis (direct CNS stimulation)
• Subsequent metabolic acidosis (uncoupling, lactate production)
• Compensation failure leads to respiratory acidosis

Toxidrome Recognition

Anticholinergic Crisis:

• Hyperthermia without diaphoresis
• Mydriasis with photophobia
• Dry mucous membranes
• Urinary retention
• Decreased bowel sounds
• Agitation, delirium, hallucinations

Cholinergic Crisis (SLUDGE):

• Salivation, Lacrimation, Urination
• Defecation, Gastric cramping, Emesis
• Miosis, muscle fasciculations
• Bradycardia, bronchorrhea

[CLINICAL_PEARL] "Wet and slow" describes cholinergic toxicity vs. "dry and fast" for anticholinergic poisoning.

Acetaminophen Toxicity Diagnosis

Essential Laboratory Tests:

• Serum acetaminophen level at 4+ hours post-ingestion
• Comprehensive metabolic panel (glucose, creatinine)
• Liver function tests (ALT, AST, bilirubin, albumin)
• Coagulation studies (PT/INR)
• Arterial blood gas if severe

[HIGH_YIELD] Rumack-Matthew Nomogram (for acute ingestions only):

Treatment thresholds at specific time points: 4 hours: 150 μg/mL (993 μmol/L) 8 hours: 75 μg/mL (497 μmol/L) 12 hours: 37.5 μg/mL (248 μmol/L) 16 hours: 18.8 μg/mL (124 μmol/L) 20 hours: 9.4 μg/mL (62 μmol/L) 24 hours: 4.7 μg/mL (31 μmol/L)

Nomogram Limitations:

• Not valid for extended-release preparations
• Not valid for chronic ingestions
• Not valid if time of ingestion unknown
• Not valid for co-ingestions affecting absorption

Salicylate Toxicity Diagnosis

Key Laboratory Findings:

• Serum salicylate level >30 mg/dL (2.2 mmol/L) suggests toxicity
• Mixed acid-base disorder on ABG
• Anion gap metabolic acidosis
• Respiratory alkalosis initially
• Hypoglycemia or normal glucose with CNS symptoms
• Prolonged PT/INR
• Elevated lactate

[CLINICAL_PEARL] Salicylate levels correlate poorly with severity in chronic poisoning. Clinical assessment is more important than absolute levels.

Diagnostic Criteria for Severe Salicylate Toxicity:

• ✓ Altered mental status
• ✓ Pulmonary edema
• ✓ Serum level >100 mg/dL (7.2 mmol/L) acute or >60 mg/dL (4.3 mmol/L) chronic
• ✓ Severe acidosis (pH <7.2)
• ✓ CNS symptoms with any detectable level

Toxidrome-Based Diagnosis

Clinical Decision Algorithm:

Step 1: Assess vital signs and mental status ├─ Hyperthermic + Dry → Consider anticholinergic ├─ Hyperthermic + Wet → Consider cholinergic └─ Hypothermic + Depressed → Consider sedative/opioid

Step 2: Examine pupils ├─ Mydriatic → Anticholinergic, sympathomimetic ├─ Miotic → Cholinergic, opioid └─ Normal → Sedative-hypnotic

Step 3: Assess skin and secretions ├─ Dry skin/mucosa → Anticholinergic ├─ Diaphoretic → Sympathomimetic, cholinergic └─ Normal → Other toxidromes

[KEY_CONCEPT] Comprehensive toxicology screening is rarely useful in acute management. Target specific substances based on clinical presentation and history.

Acetaminophen Toxicity Management

Treatment Algorithm:

Acute Acetaminophen Ingestion ↓ Obtain level at 4+ hours post-ingestion ↓ Plot on Rumack-Matthew Nomogram ├─ Above treatment line → Start NAC ├─ Below treatment line → Monitor └─ Unknown time/chronic → Consider NAC if clinical suspicion ↓ NAC Administration: • Loading: 150 mg/kg IV over 1 hour • Maintenance 1: 50 mg/kg IV over 4 hours
• Maintenance 2: 100 mg/kg IV over 16 hours ↓ Monitor: ALT, AST, INR, creatinine every 12-24 hours

[HIGH_YIELD] N-Acetylcysteine (NAC) Administration:

• Most effective within 8 hours of ingestion
• Still beneficial up to 24 hours (possibly beyond)
• Continue until ALT normalizing and INR <2.0
• Extend duration if ongoing hepatotoxicity

NAC Adverse Effects:

• Anaphylactoid reactions (8-20% of patients)
• More common with rapid IV infusion
• Managed with antihistamines and corticosteroids
• Do not discontinue NAC for mild reactions

[CLINICAL_PEARL] Never delay NAC for nomogram results if high suspicion of significant ingestion >8 hours ago.

Salicylate Toxicity Management

Immediate Interventions:

• Activated charcoal if <1-2 hours post-ingestion
• IV fluids for volume expansion and enhanced elimination
• Sodium bicarbonate for urine alkalinization (goal urine pH 7.5-8.0)
• Glucose administration even with normal serum glucose
• Temperature control with cooling measures

Enhanced Elimination Protocol:

Salicylate Level Interpretation: ├─ <30 mg/dL: Generally nontoxic ├─ 30-70 mg/dL: Mild-moderate toxicity ├─ 70-100 mg/dL: Severe toxicity └─ >100 mg/dL: Life-threatening

Treatment Based on Severity: Mild → Supportive care + alkaline diuresis Moderate → Alkaline diuresis + close monitoring Severe → Consider hemodialysis

Hemodialysis Indications:

• Salicylate level >100 mg/dL (acute) or >60 mg/dL (chronic)
• Altered mental status with any detectable level
• Pulmonary edema
• Severe acidosis (pH <7.2)
• Progressive deterioration despite optimal care

Toxidrome-Specific Antidotes

[KEY_CONCEPT] Flumazenil is contraindicated in mixed overdoses, seizure disorders, or chronic benzodiazepine use due to precipitation of seizures.

Supportive Care Priorities:

• Airway protection for altered mental status
• Cardiovascular monitoring and support
• Temperature regulation
• Electrolyte correction
• Seizure management with benzodiazepines first-line

Acetaminophen Toxicity Complications

Acute Complications:

• Fulminant hepatic failure (most common cause in US)
• Coagulopathy with bleeding risk
• Hypoglycemia from impaired gluconeogenesis
• Metabolic acidosis with lactate elevation
• Acute kidney injury (direct nephrotoxicity)
• Cerebral edema with hepatic encephalopathy

[HIGH_YIELD] King's College Criteria for Liver Transplantation:

Acetaminophen-Induced ALF:

• pH <7.3 after fluid resuscitation, OR
• All three: PT >100 sec (INR >6.5), Creatinine >3.4 mg/dL, Grade 3-4 encephalopathy

Monitoring Protocol:

Daily Assessment: • ALT, AST, bilirubin, albumin • PT/INR, platelet count • Creatinine, electrolytes • Arterial blood gas • Mental status examination

Red Flags for Transplant Evaluation: ├─ Rising INR despite NAC ├─ Worsening encephalopathy
├─ Developing acute kidney injury └─ Metabolic acidosis (lactate >3.5)

Salicylate Toxicity Complications

Neurological Complications:

• Cerebral edema (especially children <4 years)
• Seizures from CNS toxicity
• Coma in severe cases
• Permanent hearing loss (rare)

Pulmonary Complications:

• Noncardiogenic pulmonary edema (adults >30 years)
• ARDS in severe cases
• Aspiration pneumonia from altered mental status

Metabolic Complications:

• Severe metabolic acidosis
• Hypoglycemia (especially children)
• Hyperthermia with rhabdomyolysis
• Coagulopathy from decreased vitamin K synthesis

[CLINICAL_PEARL] Pulmonary edema from salicylates is high-protein (unlike cardiogenic) and responds poorly to diuretics.

Monitoring Requirements:

• Serial salicylate levels every 2-4 hours until declining
• Frequent ABGs to monitor acid-base status
• Hourly urine output during alkaline diuresis
• Core temperature monitoring
• Neurological assessments every hour

Toxidrome Complications

Anticholinergic Crisis:

• Severe hyperthermia (>106°F/41°C)
• Rhabdomyolysis from hyperthermia
• Seizures (especially with TCAs)
• Cardiac arrhythmias (sodium channel blockade)

Cholinergic Crisis:

• Respiratory failure from bronchospasm and secretions
• Cardiovascular collapse
• Intermediate syndrome (delayed paralysis 24-96 hours)
• Organophosphate-induced delayed neuropathy (weeks later)

Sympathomimetic Toxicity:

• Hyperthermia and rhabdomyolysis
• Intracranial hemorrhage
• Acute coronary syndrome
• Aortic dissection

[KEY_CONCEPT] Intermediate syndrome in organophosphate poisoning presents as weakness 1-4 days after apparent recovery, requiring prolonged mechanical ventilation.

Acetaminophen Toxicity Outcomes

Prognostic Factors:

• Time to NAC administration (most important factor)
• Peak ALT level and rate of rise
• INR normalization rate
• Presence of encephalopathy
• Development of acute kidney injury

[HIGH_YIELD] Survival Rates by NAC Timing:

• <8 hours: >95% survival without transplantation
• 8-16 hours: 80-90% survival
• 16-24 hours: 60-70% survival
• >24 hours: Variable, depends on clinical presentation

Recovery Timeline:

• ALT peak: Typically 72-96 hours post-ingestion
• INR normalization: Usually 3-7 days with recovery
• Complete recovery: Most patients within 2-4 weeks
• Chronic sequelae: Rare with appropriate treatment

Salicylate Toxicity Prognosis

Mortality Risk Factors:

• Age >65 years (higher mortality)
• Chronic vs. acute ingestion (worse prognosis)
• Delayed recognition and treatment
• Development of pulmonary edema
• CNS symptoms at presentation

Expected Recovery:

• Mild toxicity: Complete recovery in 24-48 hours
• Moderate toxicity: Recovery over 3-7 days
• Severe toxicity: May require weeks for complete recovery
• Hearing effects: Usually reversible within days to weeks

[CLINICAL_PEARL] Chronic salicylate poisoning has higher mortality despite lower salicylate levels due to delayed recognition and greater tissue penetration.

Long-term Monitoring

Post-Acetaminophen Toxicity:

Follow-up Schedule: Week 1: Daily LFTs until normalizing Week 2-4: LFTs every 3-7 days
Month 1-3: Monthly LFTs if abnormal Beyond 3 months: Routine care if normal

Red Flags for Hepatology Referral: ├─ Persistently elevated LFTs >4 weeks ├─ Evidence of chronic liver disease ├─ Recurrent acetaminophen overdoses └─ Concurrent liver disease risk factors

Post-Salicylate Toxicity:

• Audiometry if hearing complaints persist >1 week
• Pulmonary function if respiratory symptoms
• Neurological assessment if cognitive complaints
• Psychiatric evaluation for intentional overdoses

Prevention Strategies:

• Patient education about acetaminophen dosing limits
• Medication reconciliation to avoid inadvertent combinations
• Child-resistant packaging and proper storage
• Recognition of at-risk populations (chronic pain patients)

[KEY_CONCEPT] Maximum safe acetaminophen dose: 3-4 g/day in healthy adults, reduced to 2-3 g/day in elderly or liver disease patients.

Quality of Life Outcomes:

• Most patients with prompt treatment have excellent long-term outcomes
• Liver transplant recipients have 85-90% five-year survival
• Chronic complications are rare with appropriate management
• Psychological support important for intentional overdoses